Role of Hypertonic Sodium Lactate in Traumatic Brain Injury Management.
Muhammad Reza Arifianto, Achmad Zuhro Ma'ruf, Arie Ibrahim, Abdul Hafid Bajamal
Author Information
Muhammad Reza Arifianto: Department of Neurosurgery, Kanudjoso Djatiwibowo Hospital, Balikpapan, Indonesia.
Achmad Zuhro Ma'ruf: Department of Neurosurgery, Kanudjoso Djatiwibowo Hospital, Balikpapan, Indonesia.
Arie Ibrahim: Department of Neurosurgery, AW Syahranie Hospital / Faculty of Medicine - Mulawarman University, Samarinda, Indonesia.
Abdul Hafid Bajamal: Department of Neurosurgery, Dr. Soetomo General Hospital / Faculty of Medicine - Airlangga University, Surabaya, Indonesia.
Traumatic brain injury (TBI) following increased intracranial pressure (ICP) is a neuroemergency case which should be managed promptly to prevent secondary brain injury. This will lead to a condition called cerebral energy dysfunction which is an important determinant factor toward worse outcome. Lactate, which was historically known as an end waste product, now is considered as an alternative cerebral energetic fuel. Hypertonic sodium lactate (HSL) is a promising hyperosmolar fluid which serves not only to decrease ICP but also to readily supply exogenous lactate to fulfill increased cerebral energy demand. Pioneer studies have shown the harmlessness and usefulness of HSL in treating pathological condition including TBI.
J Neurosci Res. 2001 Dec 1;66(5):790-4
[PMID: 11746403 ]
Intensive Care Med. 2014 Mar;40(3):412-21
[PMID: 24477453 ]
Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10625-9
[PMID: 7938003 ]
Asian J Neurosurg. 2016 Apr-Jun;11(2):151-9
[PMID: 27057222 ]
Front Neurosci. 2015 Feb 27;9:22
[PMID: 25774123 ]
Neurosurgery. 2006 Mar;58(3 Suppl):S7-15; discussion Si-iv
[PMID: 16710967 ]
Crit Care. 2014 Mar 25;18(2):R48
[PMID: 24666826 ]
Brain Res. 2002 Feb 22;928(1-2):156-9
[PMID: 11844482 ]
J Neurochem. 2003 Dec;87(6):1381-90
[PMID: 14713294 ]
J Neurotrauma. 2015 Jun 1;32(11):820-32
[PMID: 25594628 ]
Crit Care. 2014 Sep 05;18(5):466
[PMID: 25189175 ]
Curr Neurol Neurosci Rep. 2016 Apr;16(4):31
[PMID: 26898683 ]
Front Neurosci. 2015 Apr 08;9:112
[PMID: 25904838 ]
Cerebrovasc Dis. 2012;34(5-6):329-35
[PMID: 23154656 ]
Front Neurol. 2014 Jul 07;5:114
[PMID: 25071702 ]
J Neurotrauma. 2012 Aug 10;29(12):2181-91
[PMID: 22888957 ]
Intensive Care Med. 2009 Mar;35(3):471-9
[PMID: 18807008 ]
J Neurotrauma. 2008 Dec;25(12):1415-31
[PMID: 19118457 ]
Crit Care. 2014 Nov 07;18(6):599
[PMID: 25673151 ]
Acta Neurochir (Wien). 2007;149(9):919-27; discussion 927
[PMID: 17660938 ]
Front Neurol. 2014 Jul 16;5:121
[PMID: 25076934 ]
Surg Neurol Int. 2015 Nov 23;6:177
[PMID: 26673517 ]
Lancet. 1994 Jan 1;343(8888):16-20
[PMID: 7905041 ]
N Engl J Med. 2012 Aug 23;367(8):746-52
[PMID: 22913684 ]
J Neurotrauma. 2013 Dec 15;30(24):2031-7
[PMID: 23968221 ]
Neurosurgery. 2017 Jan 1;80(1):6-15
[PMID: 27654000 ]
Neurosurgery. 2006 Mar;58(3 Suppl):S25-46; discussion Si-iv
[PMID: 16540746 ]
Curr Opin Crit Care. 2014 Apr;20(2):133-40
[PMID: 24561705 ]
J Cereb Blood Flow Metab. 2012 Jul;32(7):1107-38
[PMID: 22186669 ]
J Clin Invest. 2013 May;123(5):1988-98
[PMID: 23543056 ]
J Cereb Blood Flow Metab. 2003 Jul;23(7):865-77
[PMID: 12843790 ]
J Neurotrauma. 2016 Apr 1;33(7):681-7
[PMID: 26421521 ]
Acta Neurochir Suppl. 2000;76:359-64
[PMID: 11450045 ]
Neurosurgery. 2006 Mar;58(3 Suppl):S16-24; discussion Si-iv
[PMID: 16710968 ]
Front Integr Neurosci. 2016 Mar 03;10:10
[PMID: 26973477 ]
Am J Emerg Med. 2009 Nov;27(9):1091-6
[PMID: 19931756 ]
Brain. 2009 Oct;132(Pt 10):2839-49
[PMID: 19700417 ]
J Cereb Blood Flow Metab. 2003 Oct;23(10):1239-50
[PMID: 14526234 ]
Shock. 2002 Oct;18(4):306-10
[PMID: 12392272 ]
J Cereb Blood Flow Metab. 2009 Nov;29(11):1780-9
[PMID: 19675565 ]
Intensive Care Med. 2013 Aug;39(8):1413-22
[PMID: 23749153 ]
